Medigus announced it received a purchased order for the MUSE system from Izasa Hospital a distributor of medical products in the hospital sector.
Medigus (NASDAQ:MDGS) announced it received a purchased order (PO) for the Medigus Ultrasonic Surgical Endostapler (MUSE) system from Izasa Hospital a distributor of medical products in the hospital sector.
As quoted in the press release:
The PO covers the cost of a MUSE system console and endoscopic device, which will be available for use on patients suffering from gastroesophageal reflux disease (GERD).
The MUSE system is a single-use flexible transoral stapler that merges the latest advancement in microvisual, ultrasonic and surgical stapling. The device comes equipped with an ultrasonic sight and range finder and a micro ScoutCam CMOS[i] camera, which enables a single physician to perform an incisionless transoral fundoplication, the procedure intended to treat the anatomical cause of GERD. As the device requires no incisions, patients generally report greater comfort during the procedure and experience reduced hospital stays by up to 50% over invasive fundoplication procedures.